Showing results (151-160 of 259) with videos related to

Sort By:
Pageof 26
Cancer Treatment Reviews|December 20, 2023
Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug conjugates (ADCs)Arianna Dri, Grazia Arpino, Giampaolo Bianchini, et al.
Cancers|August 26, 2022
Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of BreastSunil S Badve, Sanghee Cho, Xiaoyu Lu, et al.
Oncotarget|September 4, 2015
Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltrationTiziana Triulzi, Loris De Cecco, Marco Sandri, et al.
International Journal of Molecular Sciences|February 13, 2026
Intestinal Protective Effects of a Pomegranate Peel Extract in In Vitro and Ex Vivo StudiesLucia Recinella, Alessandra Acquaviva, Annalisa Bruno, et al.
BJC Reports|February 5, 2024
Artificial intelligence-powered discovery of small molecules inhibiting CTLA-4 in cancerNavid Sobhani, Dana Rae Tardiel-Cyril, Dafei Chai, et al.
JCO Precision Oncology|August 7, 2026
DPYD-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Real-World Retrospective StudyFrancesco Schettini, Alexandro Membrino, Giuseppe Di Grazia, et al.
Cell Death & Disease|July 13, 2019
Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation studyIlaria Alborelli, Daniele Generali, Philip Jermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancerDaniele Generali, Alfredo Berruti, Maria P Brizzi, et al.
Oncotarget|August 26, 2014
Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancerSiti Norasikin Mohd Nafi, Daniele Generali, Gabriela Kramer-Marek, et al.
Frontiers in Oncology|November 17, 2022
Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practiceGiuseppe Buono, Grazia Arpino, Lucia Del Mastro, et al.
Pageof 26